The investigators are studying the impact of insulin resistance on the acceleration of brain aging and testing whether increased neuron insulin resistance can be counteracted by utilization of alternate metabolic pathways (e.g., ketones rather than glucose). This study has three Arms, which together provide synergistic data. For all three Arms, subjects are tested in a within-subjects design that consists of 2-3 testing sessions, 1-14 days apart, and counter-balanced for order. Impact of fuel (glucose in one session, ketones in the other) on brain metabolism and associated functioning is measured during each session. For Arms 1-2, the primary experimental measure is functional magnetic resonance imaging (fMRI), which is used to trace the self-organization of functional networks following changes in energy supply and demand. Arm 1 tests the impact of endogenous ketones produced by switching to a low carbohydrate diet, while Arm 2 tests the impact of exogenous ketones consumed as a nutritional supplement. For Arm 3, simultaneous magnetic resonance spectroscopy/positron-emission tomography (MR/PET) is used to quantify the impact of exogenous ketones on production of glutamate and GABA, key neurotransmitters. Subjects will be given the option to participate in more than one of the Arms, but doing so is not expected nor required. Prior to scans, subjects will receive a clinician-administered History and Physical (H\&P), which includes vital signs, an oral glucose tolerance test (OGTT), and the comprehensive metabolic blood panel. These will be used to assess diabetes, kidney disease, and electrolytes. If subjects pass screening, they will be provided the option to participate in one or more Arms, which include neuroimaging. To provide a quantitative measure of time-varying metabolic activity throughout the scan, based upon quantitative models of glucose and ketone regulation, as well as to be able to implement safety stopping rules (see below), the investigators will obtain pin-prick blood samples three times: prior to the scan, following consumption of the glucose or ketone drink, and following completion of the scan. To assess effects of increased metabolic demand, the investigators measure brain response to cognitive load, transitioning from resting-state to spatial reasoning through a spatial navigation video task. To assess effects of increased metabolic supply, the investigators measure brain response to glucose or ketone bolus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
80
Martinos Center for Biomedical Research, Building 149
Charlestown, Massachusetts, United States
RECRUITINGBioengineering Building , Stony Brook University
Stony Brook, New York, United States
RECRUITINGDiet related changes in brain network stability will be assessed by fMRI BOLD measurements.
Changes in BOLD signal measurements will be observed between baseline and during a glycolytic, fasting, or ketotic state.
Time frame: Within two weeks of enrollment completion
Glucose uptake will be measured by PET, with and without ketone supplement
Continuous FDG PET infusion is used as a measure of glucose uptake during rest and task, with and without the ketone supplement.
Time frame: Within two weeks of enrollment completion
Neurotransmitter production with and without ketone supplement will be measured by magnetic resonance spectroscopy
Changes in neurotransmitter concentration under metabolic demands (i.e., task vs resting-state) with and without ketone supplement will be assessed by magnetic resonance spectroscopy.
Time frame: Within two weeks of enrollment completion
Cognitive performance will be assessed by Mini Mental State Exam (MMSE).
All subjects will undergo cognitive testing prior to MRI scanning using the MMSE exam.
Time frame: Within two weeks of enrollment completion
Cognitive performance will be assessed by CNS Vital Signs.
All subjects will undergo cognitive testing prior to MRI scanning using the CNS Vital Signs exam.
Time frame: Within two weeks of enrollment completion
Insulin resistance will be assessed by HbA1C.
All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for HbA1C.
Time frame: Within two weeks of enrollment completion
Insulin resistance will be assessed by blood insulin level.
All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for insulin during a 2-hour Oral Glucose Tolerance Test (OGTT).
Time frame: Within two weeks of enrollment completion
Insulin resistance will be assessed by blood glucose level.
All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for glucose during a 2-hour Oral Glucose Tolerance Test (OGTT).
Time frame: Within two weeks of enrollment completion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.